Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Drugs Market
Companion Animal Drugs Market Share
- Report ID: GMI4981
- Published Date: Nov 2022
- Report Format: PDF
Companion Animal Drugs Market Share
The strategic landscape of the companion animal drugs market comprises companies such as :
- Indian Immunologicals Ltd
- Agrolabo S.p.A
- Endovac Animal Health
- HIPRA
- Norbrook Holdings Limited
- Zoetis
- Chanelle Pharma
- Virbac SA
- Vetoquinol
- Merck & Co
- Elanco Animal Health
- Dechra Pharmaceuticals
- Ceva Sante
- Boehringer Ingelheim International GmbH
These players are focusing on mergers and acquisitions, business expansions, and other major strategies to strengthen their presence in the market.
Frequently Asked Questions (FAQ) :
Global market for companion animal drugs exceeded USD 13.1 billion in 2022 and is poised to depict over 6.8% CAGR through 2023-2032, considering the escalating investment in veterinary clinics.
Companion animal drugs industry value from the horses segment will cross USD 4 billion by 2032, given the ever-changing nature of viruses and the increasing equine influenza (EI) outbreaks.
Asia Pacific companion animal drugs market is poised to exhibit over 7.5% CAGR through 2023-2032, on account of the surging prevalence of zoonotic diseases.
Key players in the market include Indian Immunologicals Ltd., Agrolabo S.p.A, Endovac Animal Health, HIPRA, Vetoquinol, Merck & Co, Elanco Animal Health, Ceva Sante, and Boehringer Ingelheim International GmbH, among others.
Companion Animal Drugs Market Scope
×
Get a free sample of
Companion Animal Drugs Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below